Latest News and Press Releases
Want to stay updated on the latest news?
-
Rigrodsky & Long, P.A. Reminds Investors of Investigation of Cellular Biomedicine Group, Inc. Buyout
WILMINGTON, Del., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG) regarding possible...
-
WILMINGTON, Del., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: BioSpecifics Technologies Corp. (NASDAQ GS: BSTC) regarding possible breaches of...
-
WILMINGTON, Del., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG) regarding possible...
-
WILMINGTON, Del., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: MyoKardia, Inc. (NASDAQ GS: MYOK) regarding possible breaches of fiduciary...
-
WILMINGTON, Del., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of...
-
SAN DIEGO, Oct. 12, 2020 (GLOBE NEWSWIRE) -- National law firm Barr Law Group is investigating the actions of the officers and board of directors of Virtusa Corporation, Cellular Biomedicine Group,...
-
NEW YORK, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning...
-
WILMINGTON, Del., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Immunomedics, Inc. (NASDAQ GS: IMMU) regarding possible breaches of fiduciary...
-
WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Principia Biopharma Inc. (NASDAQ GS: PRNB) regarding possible breaches of...
-
WILMINGTON, Del., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG) regarding possible...